AYTU BIOPHARMA, INC Revenue, Net (Deprecated 2018-01-31)
AYTU BIOPHARMA, INC (AYTU) reported Revenue, Net (Deprecated 2018-01-31) of $607.47 thousand for the 3-month period ending 2018-03-31, per its 10-Q filed 2018-05-14.
Discontinued › Income Statement › Revenue
us-gaap:SalesRevenueNet · last filed 2018-05-14
- AYTU BIOPHARMA, INC revenue, net (deprecated 2018-01-31) for the quarter ending 2018-03-31 was $607.47K, a 32.02% decline year-over-year.
- AYTU BIOPHARMA, INC revenue, net (deprecated 2018-01-31) for the quarter ending 2017-12-31 was $1.05M, a 32.36% increase year-over-year.
- AYTU BIOPHARMA, INC revenue, net (deprecated 2018-01-31) for the quarter ending 2017-09-30 was $1.08M, a 54.21% increase year-over-year.
- AYTU BIOPHARMA, INC revenue, net (deprecated 2018-01-31) for the quarter ending 2017-03-31 was $893.55K, a 38.11% increase year-over-year.
| Period end | Revenue, Net (Deprecated 2018-01-31) 3 month | Revenue, Net (Deprecated 2018-01-31) 3 month as first filed | Revenue, Net (Deprecated 2018-01-31) 6 month | Revenue, Net (Deprecated 2018-01-31) 6 month as first filed | Revenue, Net (Deprecated 2018-01-31) 9 month | Revenue, Net (Deprecated 2018-01-31) 9 month as first filed |
|---|---|---|---|---|---|---|
| 2018-03-31 | $607.47K 10-Q · filed 2018-05-14 | $1.66M derived: sum of 2 quarters · filed 2018-05-14 | $2.73M 10-Q · filed 2018-05-14 | |||
| 2017-12-31 | $1.05M 10-Q · filed 2018-02-08 | $2.13M 10-Q · filed 2018-02-08 | ||||
| 2017-09-30 | $1.08M 10-Q · filed 2017-11-09 | |||||
| 2017-03-31 | $893.55K 10-Q · filed 2018-05-14 | $894.00K 10-Q · filed 2017-05-11 | $1.69M derived: sum of 2 quarters · filed 2018-05-14 | $2.39M 10-Q · filed 2018-05-14 | $2.39M 10-Q · filed 2017-05-11 | |
| 2016-12-31 | $794.17K 10-Q · filed 2018-02-08 | $794.00K 10-Q · filed 2017-02-09 | $1.49M 10-Q · filed 2018-02-08 | $1.49M 10-Q · filed 2017-02-09 | ||
| 2016-09-30 | $697.98K 10-Q · filed 2017-11-09 | $698.00K 10-Q · filed 2016-11-07 | ||||
| 2016-03-31 | $647.00K 10-Q · filed 2017-05-11 | $1.09M derived: sum of 2 quarters · filed 2017-05-11 | $1.56M 10-Q · filed 2017-05-11 | |||
| 2015-12-31 | $448.00K 10-Q · filed 2017-02-09 | $914.00K 10-Q · filed 2017-02-09 | ||||
| 2015-09-30 | $466.00K 10-Q · filed 2016-11-07 | |||||
| 2015-03-31 | $2.00K 10-Q · filed 2016-05-11 | $9.00K derived: sum of 2 quarters · filed 2016-05-11 | $15.00K 10-Q · filed 2016-05-11 | |||
| 2014-12-31 | $7.00K 10-Q · filed 2016-02-11 | $13.00K 10-Q · filed 2016-02-11 | ||||
| 2014-09-30 | $6.00K 10-Q · filed 2015-11-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |